+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Psychobiotic Supplements Market by Product Type (Capsules, Chewables, Liquid Supplements), Probiotic Strain (Bifidobacterium, Lactobacillus, Streptococcus thermophilus), Source, Distribution Channel, Application, End-User - Global Forecast 2025-2030- Product Image
Psychobiotic Supplements Market by Product Type (Capsules, Chewables, Liquid Supplements), Probiotic Strain (Bifidobacterium, Lactobacillus, Streptococcus thermophilus), Source, Distribution Channel, Application, End-User - Global Forecast 2025-2030- Product Image
Sale

Psychobiotic Supplements Market by Product Type (Capsules, Chewables, Liquid Supplements), Probiotic Strain (Bifidobacterium, Lactobacillus, Streptococcus thermophilus), Source, Distribution Channel, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6090378
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Psychobiotic Supplements Market grew from USD 372.84 million in 2024 to USD 406.58 million in 2025. It is expected to continue growing at a CAGR of 9.45%, reaching USD 641.11 million by 2030.

Comprehensive Introduction to the Psychobiotic Supplements Domain Emphasizing Evolving Neuroscience Insights, Consumer Wellness Priorities, and Industry Innovation Drivers

Psychobiotic supplements represent an evolving frontier at the confluence of microbiome science and mental wellness, offering consumers innovative pathways to support cognitive and emotional health. Emerging research into the gut-brain axis highlights how select probiotic strains can influence neurotransmitter production and stress resilience, creating a new wellness paradigm. In tandem with this scientific momentum, consumer demand for holistic health solutions has intensified, driven by increasing awareness of the interconnectedness between dietary habits and psychological well-being. As a result, manufacturers are channeling resources into advanced formulations and clinical studies to substantiate claims and differentiate their offerings.

Against this backdrop, the psychobiotic supplements domain has witnessed a surge in product innovation and marketing sophistication. Brands are exploring novel delivery mechanisms that enhance bioavailability, while academic collaborations are yielding insights into strain-specific benefits. Transitioning from generic probiotic positioning to targeted mental health support, the industry is forging alliances with healthcare professionals and leveraging digital platforms to educate consumers. Consequently, this introduction sets the stage for a comprehensive exploration of transformative shifts, regulatory influences, and strategic imperatives shaping the future of psychobiotic supplements.

Analysis of Transformative Shifts in Psychobiotic Supplementation Catalyzed by Scientific Advances, Regulatory Evolutions, and Consumer Behavioral Changes

The psychobiotic supplements landscape is undergoing transformative shifts propelled by breakthroughs in neuroscience, advances in formulation technologies, and evolving consumer expectations. As high-throughput sequencing and metabolomic profiling tools become more accessible, researchers are uncovering strain-specific mechanisms of action that inform product design. This transition from broad-spectrum probiotic offerings toward precision-targeted blends has elevated efficacy claims and compelled brands to substantiate mental health benefits with robust clinical evidence.

Simultaneously, regulatory agencies are clarifying classification standards for psychobiotic ingredients, fostering greater transparency while imposing rigorous safety and efficacy requirements. This regulatory evolution has prompted companies to refine their quality assurance frameworks and engage more closely with third-party laboratories. At the same time, digital health integration has emerged as a catalyst for personalization, enabling real-time monitoring of consumer responses to supplementation regimens. Together, these forces are reshaping the competitive landscape, driving collaboration across industry, academia, and healthcare, and ultimately redefining how psychobiotic solutions are developed, marketed, and adopted.

Evaluation of the Cumulative Impact of 2025 United States Tariff Measures on Psychobiotic Supply Chains, Pricing Structures, and Competitive Dynamics

The imposition of new United States tariffs in 2025 has exerted a profound influence on the psychobiotic supplements supply chain, compelling manufacturers and distributors to reassess sourcing strategies and cost structures. Raw ingredients derived from specialized probiotic cultures and substrate matrices have seen increased import costs, prompting a rise in negotiations with domestic suppliers and investments in localized production capabilities. In response, several market participants have pursued strategic partnerships with contract manufacturing organizations to mitigate tariff-related price pressures and maintain margin stability.

Moreover, the tariff environment has disproportionately affected niche segments reliant on high-purity strains that originate from overseas research facilities. As a consequence, some companies have shifted toward broader strain portfolios that can be sourced domestically, balancing efficacy considerations against economic realities. Throughout this period, pricing strategies have been adjusted with greater emphasis on value-added services-such as clinical validation and digital support programs-to justify premium positioning. Hence, the cumulative impact of these tariffs has not only altered cost dynamics but also accelerated strategic realignments within the psychobiotic supplements sector.

Critical Segmentation Insights Unveiling Market Dynamics Across Product Formulations Strain Variations Source Origins Distribution Channels Applications and End User Profiles

A nuanced understanding of market segmentation reveals how distinct product and consumer categories drive performance across the psychobiotic supplements industry. Capsules and chewables maintain strong consumer appeal due to their ease of use and precise dosing, while liquid supplements and powders cater to those seeking customizable regimens or integration into functional beverages. Strain diversity further shapes product differentiation, with Bifidobacterium variants favored for mood regulation, Lactobacillus strains prioritized for stress resilience, and Streptococcus thermophilus emerging in specialized formulations targeting cognitive clarity.

Source origin influences purchasing decisions as animal-based extracts are perceived to deliver robust live cultures, whereas plant-based alternatives resonate with vegan and clean-label consumers. In distribution, conventional brick-and-mortar retail continues to attract shoppers through pharmacy endorsements and in-store expert consultations at specialty outlets and supermarkets, even as online channels capture interest through subscription models and direct-to-consumer platforms. Applications extend beyond nutritional supplements into functional foods and beverages, while animal feed formulations signal cross-industry expansion. Finally, end-user demographics from children to adults and the elderly dictate tailored messaging and dosage specifications, underscoring the importance of segmentation in guiding product development and marketing strategies.

Essential Regional Insights Highlighting Psychobiotic Market Growth Drivers and Consumer Trends Across the Americas Europe Middle East & Africa and Asia Pacific Regions

Regional dynamics in the psychobiotic supplements market reflect a tapestry of cultural preferences, regulatory frameworks, and supply chain infrastructures across global territories. In the Americas, consumer embrace of mental wellness routines and the prevalence of health-forward retail channels have bolstered demand for clinically validated psychobiotic blends. Meanwhile, governmental support for nutraceutical innovation in North America has accelerated product approvals and collaborative research initiatives, positioning the region as a hub for pioneering clinical trials.

Across Europe, Middle East & Africa, regulatory harmonization efforts are shaping cross-border trade, while rising incidence of stress-related disorders has fueled interest in gut-brain axis interventions. Market participants are leveraging established healthcare networks in Western Europe and exploring emerging economies in the Middle East to introduce localized formulations. In Asia Pacific, robust manufacturing capabilities and a strong tradition of probiotic consumption underpin rapid growth, particularly within functional beverage segments. Regional research centers in Japan and Australia are advancing strain development, and digital health adoption is enabling highly personalized psychobiotic solutions tailored to diverse demographic profiles.

Strategic Insights into Leading Industry Players Shaping the Psychobiotic Supplements Sector Through Innovation Partnerships and Portfolio Diversification

Leading stakeholders are redefining the psychobiotic supplements space through strategic innovation, mergers, and targeted research collaborations. Global food and nutrition entities are expanding their mental wellness portfolios by integrating proven probiotic strains with botanical extracts, while specialized biotech firms are securing intellectual property on novel bacterial strains optimized for neurological support. Collaborative ventures with academic institutions and clinical research organizations have emerged as critical pathways to validate functional claims and expedite product registrations.

In addition, companies with vertically integrated supply chains are achieving competitive advantage by controlling strain cultivation, formulation processes, and quality assurance protocols from raw material to finished dosage form. Regional players with deep distribution networks are forging alliances with digital health platforms to deliver subscription services that reinforce brand loyalty and adherence. These strategic initiatives collectively underscore a trend toward consolidation and differentiation, as industry leaders strive to capture value through robust R&D, agile manufacturing, and consumer-centric service models.

Actionable Strategic Recommendations Guiding Industry Leaders Toward Effective Innovation Market Penetration and Regulatory Compliance in the Psychobiotics Sector

Industry leaders should prioritize investments in precision strain research to support targeted mental health outcomes, ensuring claims are underpinned by rigorous clinical data. By fostering cross-functional collaborations between microbiologists, neuroscientists, and formulation experts, organizations can accelerate innovation cycles and strengthen regulatory submissions. Furthermore, diversifying delivery formats to include gummies, effervescent tablets, and ready-to-drink options will cater to evolving consumer preferences for convenience and taste.

Building resilient supply chains through regional production hubs can mitigate geopolitical and tariff-related risks while reducing lead times. Concurrently, implementing advanced digital platforms for consumer engagement enables real-time feedback loops and personalized supplementation guidance. Lastly, proactively engaging with regulatory authorities to shape future policy frameworks will secure first-mover advantage and foster long-term market access, positioning companies for sustainable growth in the psychobiotic supplements landscape.

Rigorous Research Methodology Employing Integrated Primary and Secondary Approaches for Comprehensive Psychobiotic Market Analysis

This analysis integrates both primary and secondary research methodologies to deliver comprehensive market insights. Primary research involved in-depth interviews with industry executives, formulation scientists, and key opinion leaders in gastroenterology and psychiatry, providing firsthand perspectives on product efficacy and emerging clinical trends. Secondary research encompassed a systematic review of scientific journals, patents, and regulatory filings, as well as an examination of corporate disclosures and investor presentations to validate strategic direction and competitive positioning.

Quantitative data points were triangulated across multiple sources to ensure consistency, with qualitative findings refined through expert workshops and peer reviews. The research team employed rigorous data validation processes at each stage, ensuring the integrity and reliability of conclusions. This blended approach yields a robust understanding of market dynamics, segmentation drivers, and strategic imperatives, equipping stakeholders with actionable intelligence for informed decision-making.

Conclusive Perspectives Synthesizing Market Trends Strategic Imperatives and Future Opportunities in the Global Psychobiotic Supplements Landscape

The confluence of advanced microbiome research, evolving consumer expectations, and shifting regulatory landscapes is redefining the psychobiotic supplements industry. Strategic innovation in strain selection and delivery formats, coupled with resilient supply chain strategies, will distinguish market leaders from followers. Regional variations highlight the necessity of localized approaches, while tariff impacts underscore the importance of diversified sourcing and regulatory engagement.

As the sector matures, companies that align rigorous clinical validation with digital consumer experiences will capture market share and foster brand loyalty. The insights presented herein provide a strategic blueprint, illuminating pathways to innovation, territorial expansion, and sustainable growth. Ultimately, the psychobiotic supplements landscape will be shaped by those organizations capable of integrating scientific excellence with agile commercialization strategies.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Capsules
    • Chewables
    • Liquid Supplements
    • Powders
  • Probiotic Strain
    • Bifidobacterium
    • Lactobacillus
    • Streptococcus thermophilus
  • Source
    • Animal-Based
    • Plant-Based
  • Distribution Channel
    • Offline Retail
      • Pharmacies
      • Specialty Stores
      • Supermarkets & Hypermarkets
    • Online Retail
  • Application
    • Animal Feed
    • Functional Foods & Beverages
    • Nutritional Supplements
  • End-User
    • Adults
    • Children
    • Elderly
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Abbott Laboratories
  • Bened Life, Inc.
  • BioGaia AB
  • Danone SA
  • Dr. Ohhira’s Probiotics
  • Enzymedica Group
  • HUM Nutrition Inc.
  • Institut Allergosan Pharma GmbH
  • Jarrow Formulas, Inc.
  • Kerry Group
  • Lallemand Health Solutions Inc.:
  • Nestlé S.A
  • NortemChem SA
  • Novonesis Group
  • NOW Health Group, Inc.
  • Pendulum Therapeutics, Inc.
  • Probi AB
  • Seed Health, Inc.
  • Sova Health
  • WPP Company

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing consumer demand for clean label and sustainably sourced psychobiotic ingredients
5.2. Increasing clinical trial evidence linking psychobiotic strains to anxiety and depression relief
5.3. Emergence of personalized psychobiotic formulations based on individual microbiome profiles
5.4. Adoption of AI-driven strain discovery and formulation optimization in psychobiotic development
5.5. Integration of digital health platforms for personalized dosage tracking and mental wellness support
5.6. Regulatory advancements shaping global psychobiotic supplement claims and labeling standards
5.7. Emerging research on psychobiotic impact in cognitive performance and stress resilience enhancement
5.8. Expansion of direct-to-consumer subscription models for tailored psychobiotic supplement delivery
5.9. Hybrid formulations combining psychobiotics with nootropics to target mood and cognitive function
5.10. Mounting focus on bioavailability and encapsulation technologies in psychobiotic supplement design
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Psychobiotic Supplements Market, by Product Type
8.1. Introduction
8.2. Capsules
8.3. Chewables
8.4. Liquid Supplements
8.5. Powders
9. Psychobiotic Supplements Market, by Probiotic Strain
9.1. Introduction
9.2. Bifidobacterium
9.3. Lactobacillus
9.4. Streptococcus thermophilus
10. Psychobiotic Supplements Market, by Source
10.1. Introduction
10.2. Animal-Based
10.3. Plant-Based
11. Psychobiotic Supplements Market, by Distribution Channel
11.1. Introduction
11.2. Offline Retail
11.2.1. Pharmacies
11.2.2. Specialty Stores
11.2.3. Supermarkets & Hypermarkets
11.3. Online Retail
12. Psychobiotic Supplements Market, by Application
12.1. Introduction
12.2. Animal Feed
12.3. Functional Foods & Beverages
12.4. Nutritional Supplements
13. Psychobiotic Supplements Market, by End-User
13.1. Introduction
13.2. Adults
13.3. Children
13.4. Elderly
14. Americas Psychobiotic Supplements Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Psychobiotic Supplements Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Psychobiotic Supplements Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Bened Life, Inc.
17.3.3. BioGaia AB
17.3.4. Danone SA
17.3.5. Dr. Ohhira’s Probiotics
17.3.6. Enzymedica Group
17.3.7. HUM Nutrition Inc.
17.3.8. Institut Allergosan Pharma GmbH
17.3.9. Jarrow Formulas, Inc.
17.3.10. Kerry Group
17.3.11. Lallemand Health Solutions Inc.:
17.3.12. Nestlé S.A
17.3.13. NortemChem SA
17.3.14. Novonesis Group
17.3.15. NOW Health Group, Inc.
17.3.16. Pendulum Therapeutics, Inc.
17.3.17. Probi AB
17.3.18. Seed Health, Inc.
17.3.19. Sova Health
17.3.20. WPP Company
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. PSYCHOBIOTIC SUPPLEMENTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PSYCHOBIOTIC SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PSYCHOBIOTIC SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. PSYCHOBIOTIC SUPPLEMENTS MARKET: RESEARCHAI
FIGURE 28. PSYCHOBIOTIC SUPPLEMENTS MARKET: RESEARCHSTATISTICS
FIGURE 29. PSYCHOBIOTIC SUPPLEMENTS MARKET: RESEARCHCONTACTS
FIGURE 30. PSYCHOBIOTIC SUPPLEMENTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PSYCHOBIOTIC SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY CHEWABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY CHEWABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY LIQUID SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY LIQUID SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY POWDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY STREPTOCOCCUS THERMOPHILUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY STREPTOCOCCUS THERMOPHILUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ANIMAL-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ANIMAL-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PLANT-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SUPERMARKETS & HYPERMARKETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ANIMAL FEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY FUNCTIONAL FOODS & BEVERAGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY FUNCTIONAL FOODS & BEVERAGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY CHILDREN, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 98. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 99. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 100. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 101. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 104. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 105. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 108. CANADA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 109. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 112. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 113. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 122. MEXICO PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 181. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 184. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 185. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 190. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 191. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 194. GERMANY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 195. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 198. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 199. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 204. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 205. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 208. FRANCE PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 223. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 226. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 227. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 228. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 229. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 232. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 233. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 236. ITALY PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 237. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 240. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 241. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 246. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 247. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 250. SPAIN PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 293. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 294. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 295. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 296. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 297. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 298. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 302. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 303. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 306. DENMARK PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY OFFLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 321. QATAR PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. QATAR PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. QATAR PSYCHOBIOTIC SUPPLEMENTS MARKET SIZE, BY PROBIOTIC STRAIN, 201

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Psychobiotic Supplements market report include:
  • Abbott Laboratories
  • Bened Life, Inc.
  • BioGaia AB
  • Danone SA
  • Dr. Ohhira’s Probiotics
  • Enzymedica Group
  • HUM Nutrition Inc.
  • Institut Allergosan Pharma GmbH
  • Jarrow Formulas, Inc.
  • Kerry Group
  • Lallemand Health Solutions Inc.:
  • Nestlé S.A
  • NortemChem SA
  • Novonesis Group
  • NOW Health Group, Inc.
  • Pendulum Therapeutics, Inc.
  • Probi AB
  • Seed Health, Inc.
  • Sova Health
  • WPP Company

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 406.58 Million
Forecasted Market Value ( USD ) by 2030 $ 641.11 Million
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

2025 Psychobiotic Supplements Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032) - Product Image

2025 Psychobiotic Supplements Market Report - Industry Size, Competition, Trends and Growth Opportunities by Region - Forecast by Types and Applications (2024-2032)

  • Report
  • 147 Pages
  • Global
From
Probiotics Market by Product Type (Dietary Supplements, Feed, Food & Beverage), Source (Bacteria, Yeast), Application, End-User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Probiotics Market by Product Type (Dietary Supplements, Feed, Food & Beverage), Source (Bacteria, Yeast), Application, End-User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Probiotics Market (2025 Edition): Analysis By Product Type (Functional Food & Beverages, Dietary Supplements, and Animal Feed), By Ingredient, By Application, By Region, By Country: Market Insights and Forecast (2021-2031) - Product Image

Probiotics Market (2025 Edition): Analysis By Product Type (Functional Food & Beverages, Dietary Supplements, and Animal Feed), By Ingredient, By Application, By Region, By Country: Market Insights and Forecast (2021-2031)

  • Report
  • 221 Pages
  • Global
From
Probiotics Dietary Supplements Market by Product (Capsules, Powder, Tablets), Strain (Bifidobacterium, Lactobacillus, Streptococcus), Formulation, Distribution Channel, Application, End-user - Global Forecast 2025-2030 - Product Image

Probiotics Dietary Supplements Market by Product (Capsules, Powder, Tablets), Strain (Bifidobacterium, Lactobacillus, Streptococcus), Formulation, Distribution Channel, Application, End-user - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Men's Health Supplements Market Size, Share & Trends Analysis Report by Type (Sports Supplements, Reproductive Health Supplements), Age Group, Formulation, Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Men's Health Supplements Market Size, Share & Trends Analysis Report by Type (Sports Supplements, Reproductive Health Supplements), Age Group, Formulation, Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.